Myosin light chains mechanisms

In the presence of calcium, the primary contractile protein, myosin, is phosphorylated by the myosin light-chain kinase initiating the subsequent actin-activation of the myosin adenosine triphosphate activity and resulting in muscle contraction. Removal of calcium inactivates the kinase and allows the myosin light chain to dephosphorylate myosin which results in muscle relaxation. Therefore the general biochemical mechanism for the muscle contractile process is dependent on the avaUabUity of a sufficient intraceUular calcium concentration. 

Of the several kinase activities which are important in smooth muscle, myosin light chain kinase, MLCK, is the one responsible for activation of the actin-myosin system to in vivo levels. MLCK is present in the other nonmuscle cell types which have the actin-myosin contractile system and all of these are probably activated in a manner similar to smooth muscle rather than by way of the Ca -troponin mechanism of striated muscle. MLCK from smooth muscle is about 130 kDa and is rather variable in shape. It is present in smooth muscle in 1-4 pM concentrations and binds with an equally high affinity to both myosin and actin. Thus, most MLCK molecules are bound to actin. Myosin light chain serine-19 is the primary target of smooth muscle myosin light chain kinase. 

Wier It seems reasonable to think that these waves may serve to spike up the phosphorylation of myosin light chain. In combination with the Ca2+ sensitizing mechanisms, this force can be maintained. 

The best characterized substrate of Ca Vcalmodulin is the Ca /calmodulin-depen-dent protein kinase (CaM kinase). CaM kinase has an important function in neuronal signal transduction. The mechanism of Ca Vcalmodulin activation of CaM kinase is described in more detail in Section 7.4, together with regulation of protein kinases. Another substrate of Ca Vcalmodulin is myosin light chain kinase (MLCK), involved in contraction of smooth musculature. 

Mechanism of action of nitrates, nitrites, and other substances that increase the concentration of nitric oxide (NO) in vascular smooth muscle cells. Steps leading to relaxation are shown with heavy arrows. MLCK, activated myosin light-chain kinase [see Figure 12-1]. GC, activated guanylyl cyclase PDE, phosphodiesterase eNOS, endothelial nitric oxide synthase. 

Hydralazine causes direct relaxation of arteriolar smooth muscle. The arteriolar vasodilatation produced by hydralazine requires an intact endothelium. Therefore, one proposed mechanism of action is that hydralazine liberates nitric oxide from the endothelium (similar to the nitrates), which in turn increases cGMP to ultimately prevent the phosphorylation of myosin light chain (which is required for smooth muscle contraction) resulting in arteriolar vasorelaxation. 

An enhancement of ATPase action comes through the phosphorylation of myosin light chains (MW 18,000). The phosphorylation is achieved because the high cellular [Ca2+] activates myosin kinase, an enzyme that contains calmodulin, a Ca2+-binding subunit. Phosphorylation of myosin is absolutely required for smooth muscle contraction, though not for the contraction of skeletal or cardiac muscle, because smooth muscle has no troponin. Thus, whereas contraction and relaxation in skeletal and cardiac muscle are achieved principally via the action of Ca2+ on troponin, in smooth muscle they must depend solely on the Ca2+-dependent phosphorylation of myosin. In skeletal and cardiac muscle, once the stimulus to the sarcolemma is removed, [Ca2+] in sarcoplasm drops rapidly back to 10 7 or 10 8 M via various Ca2+ pump mechanisms present in the sarcoplasmic reticulum, and tropomyosin can once again interfere with the myosin-actin interaction. 

---